In addition, they found that DAC-induced NY-ESO-1 gene expression was reduced by the use of the BRAF inhibitor, PLX4720 [79] in some BRAF mutant thyroid cancer cell lines. The gene discussed is BRAF; the disease is thyroid gland carcinoma.